Event dossier

Eli Lilly wins US approval for weight-loss pill

New drug Foundayo sets up battle with Novo Nordisk for oral obesity drugs Grouped from 2 articles across 2 sources.

2 reports2 sourcesApr 1, 2026, 7:09 PM
FilterFinancial Times
Clustered coverageCNBC, Financial Times
Coverage timeline2
Coverage timeline

Coverage timeline

Ranked reports inside the event cluster. Open any publisher link to read the original coverage.

Financial TimesApr 1, 2026, 7:09 PM

Eli Lilly wins US approval for weight-loss pill

New drug Foundayo sets up battle with Novo Nordisk for oral obesity drugs

CNBCApr 1, 2026, 4:40 PM

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.

Related events

Related events

Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.

El Psy Congroo Newswire